monoclonal antibodies

A new order of the injectable COVID antibody bebtelovimab should meet current demand levels through August, according to the Department of Health and Human Services.

Principle LTC, operator of 45 nursing homes in the Southeast, is building on its successful role in testing a key drug for COVID-19 prevention and treatment to launch trials of a new Alzheimer drug.

Coverage of aducanumab (Aduhelm) is officially limited to clinical trials only, the agency announced Thursday. Most stakeholders have called for restricted use while more efficacy and safety data is gathered,...

The monoclonal antibody sotrovimab is no longer authorized for the treatment of COVID-19 in eight states and two territories where the omicron BA.2 sub-variant accounts for at least half of the infections.

Fully 80% of the drug’s supply is languishing on shelves while physicians remain uninformed or uncertain about the drug and its guidance, a new report finds.

The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...

Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.

Hundreds of facilities will be able to directly order COVID-19 antiviral drugs and receive direct distributions starting this month, federal officials say.

In a scenario now familiar to long-term care clinicians, the FDA has advised against prescribing the COVID-19 monoclonal antibody drug sotrovimab in locations where certain SARS-CoV-2 variants are now...

Bebtelovimab is greenlit for treatment of mild to moderate COVID-19 in patients at high risk of severe disease. The move comes amid a federal push to increase supply of effective therapies.